<?xml version="1.0" encoding="UTF-8"?>
<p>At the end of fourth stage, we obtained 96 phytochemicals (labelled T1–T96; Figure 5; 
 <xref ref-type="app" rid="app1-molecules-25-03822">Supplementary Table S1</xref>) as potential inhibitors of TMPRSS2 and 9 phytochemicals (labelled C1–C9; Figure 6; 
 <xref ref-type="app" rid="app1-molecules-25-03822">Supplementary Table S2</xref>) as potential inhibitors of cathepsin L. Using IMPPAT [
 <xref rid="B28-molecules-25-03822" ref-type="bibr">28</xref>], we provide a list of Indian medicinal plants that can produce the identified phytochemical inhibitors of TMPRSS2 and cathepsin L (
 <xref rid="molecules-25-03822-t001" ref-type="table">Table 1</xref> and 
 <xref rid="molecules-25-03822-t002" ref-type="table">Table 2</xref>; 
 <xref ref-type="app" rid="app1-molecules-25-03822">Supplementary Table S3</xref>). Furthermore, we have also compiled information on potential antiviral or anti-inflammatory use in traditional medicine of the herbal sources of the identified phytochemical inhibitors of TMPRSS2 and cathepsin L (
 <xref rid="molecules-25-03822-t001" ref-type="table">Table 1</xref> and 
 <xref rid="molecules-25-03822-t002" ref-type="table">Table 2</xref>; 
 <xref ref-type="app" rid="app1-molecules-25-03822">Supplementary Table S3</xref>). In 
 <xref ref-type="app" rid="app1-molecules-25-03822">Supplementary Tables S4 and S5</xref>, we list the ligand binding site residues and non-covalent protein-ligand interactions for the identified phytochemical inhibitors of TMPRSS2 and cathepsin L. We have also predicted the physicochemical and ADMET properties of the identified phytochemical inhibitors of TMPRSS2 and cathepsin L (
 <xref ref-type="sec" rid="sec3-molecules-25-03822">Section 3</xref>; 
 <xref ref-type="app" rid="app1-molecules-25-03822">Supplementary Tables S6 and S7</xref>).
</p>
